Guru Ownership Trend
Guru Analysis for ORIC Pharmaceuticals, Inc. (ORIC)
ORIC Pharmaceuticals, Inc. (ORIC), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $90.26 M.
Top institutional holders include Andreas Halvorsen and Chuck Royce.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $8.64 M net outflow during the quarter.
Recent activity highlights Cliff Asness who increased their stake by 110.9%. Conversely, Chuck Royce reduced exposure by 18.9%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for ORIC Pharmaceuticals, Inc. (ORIC)
Major holders include Andreas Halvorsen ($55.52 M), Chuck Royce ($10.61 M), Cliff Asness ($3.89 M). According to the latest reported data, 4 tracked investment managers collectively hold approximately 6.51 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $8.64 M, with 2 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 1 fully exited ORIC. The total reported sell value was $10.78 M.
Yes, 0 managers opened new positions in ORIC, and 2 increased their existing holdings. The total reported buy value was $2.14 M.